The Hindu | Sustainability science for FMCGs

FMCGs should be a priority target sector for ANRF, the new public-private partnership initiative, and the BioE3 policy of the government

By Shambhavi Naik

Read the full article here.

India Bioscience | How will BioE3 policy shape the Indian bioeconomy?

The Biotechnology for Economy, Environment, and Employment (BioE3) policy marks a pivotal moment for India’s life sciences sector. By prioritising bio-manufacturing, it aims to drive economic growth, environmental sustainability, and job creation. However, its success will depend on sustained funding, regulatory reforms, and the creation of interdisciplinary skill hubs. 

By Shambhavi Naik

Read the full article here.

Deccan Herald | BioE3 policy must prioritise biopharma and biomanufacturing

The BioE3 policy must prioritise sectors where current geopolitical developments have created opportunities for Indian companies to enter international markets.

By Shambhavi Naik and Saurabh Todi

Read the full article here.

Loksatta | महाराष्ट्रात जैवतंत्रज्ञानासाठी स्वतंत्र खाते हवे!

भारतीय जैव-अर्थव्यवस्थेत महाराष्ट्राचे सर्वाधिक योगदान आहे. महाराष्ट्रामुळे देशाच्या जैव-अर्थव्यवस्थेत ३७ अब्ज डॉलर्सहून अधिक रकमेची भर पडते. हे प्रमाण २७ टक्के आहे. म्हणजेच सापेक्ष मूल्य आणि प्रत्यक्ष मूल्याच्या या दोन्हींमध्ये देशाच्या जैव-अर्थव्यवस्थेत महाराष्ट्र अव्वल आहे. याचे प्राथमिक कारण म्हणजे आपले हे राज्य जैवविविधतेच्या दृष्टीने समृद्ध आहे – ७२० किमीचा समुद्रकिनारा, नऊ जैवविविधता वारसा स्थळे, विविध वनस्पती आणि प्राणी अशी जैवविविधता संपदा महाराष्ट्राला लाभली आहे.

Read the full article here.

The Hindu | Why sustainable funding matters for India’s ‘science power’ ambition

The 2024 theme for National Science Day, which India celebrates every year on February 28, is “Science for Sustainable Development”. Science and technological developments are key drivers of India’s journey towards becoming a developed country by 2047. India is committed to making this progress through sustainable means, as evidenced by its commitments under the Paris Agreement, participation in global fora for sustainable development, and reinforced in this year’s theme for Science Day. The role of science in driving sustainable development doesn’t need emphasis, but any conversation on science is incomplete without setting one key expectation: for science to transform India, it has to be sustainably and consistently funded. Read the full article here.

Deccan Herald | National Research Foundation: Old wine in a new bottle?

The Indian research community is looking to the formation of the National Research Foundation (NRF) to herald a new era — where research is one of the government’s priorities resulting in access to a reasonable quantum of funding disbursed in a timely manner. However, short of these two dramatic changes, the NRF would be reduced to just another funding avenue, riddled with the issues of the past. But even with the passing of the NRF Bill there is little clarity on whether either of these two issues will be resolved. Read the full article here.

The Hindu | Do we need a radical alternative to scientific publishing?

Scientific publishing is a necessary component of scientists’ efforts to establish a career in science for themselves. The process allows for scientists’ peers to enrich new findings by reviewing papers, curates research from scientists across the world, and signals the credibility of some scientific work. Read the full article here.

Hindustan Times | NRF is a game changer. But it needs more clarity

The National Research Foundation (NRF) is India’s largest government programme to fund research till date. India’s gross expenditure on research and development (GERD) is currently 0.6-0.8% of the Gross Domestic Product (GDP), quite low when compared with that of the United States (US) (3.36%), China (2.14%), and Israel (4.9%). A significant infusion of funding, steered by a clear implementation strategy, is required for India to become a science leader. The NRF bill is an excellent start to driving India’s research agenda but it needs to clarify its objectives and create capacity for their achievement. Read the full article here.

The Hindu | Explained | The problem with India’s new guidelines on genetically modified insects

India’s bioeconomy contributes 2.6% to the GDP. In April 2023, the Department of Biotechnology (DBT) released its ‘Bioeconomy Report 2022’  report, envisioning this contribution to be closer to 5% by 2030. This ambitious leap – of $220 billion in eight years – will require aggressive investment and policy support. But neither funding for the DBT, India’s primary promoter of biotechnology, nor its recent policies reflect any serious intention to uplift this sector. Along with more money, policies that enable risk-taking appetite within Indian scientists will be required to create an ecosystem of innovation and industrial action. Read the full article here.

Rajasthan Patrika | India-U.S Biotechnology Cooperation

Read the full article here.

The Hindu | India as a Quad-led biomanufacturing hub

In March 2021, the Quad (Australia, India, Japan, and the United States) set up a Critical and Emerging Technology Working Group to facilitate cooperation, monitor trends, and scout for opportunities related to developments in critical and emerging technologies, that included biotechnology. However, the potential for Quad cooperation in biotechnology remains insufficiently tapped. The establishment of a Quad-led biomanufacturing hub in India will give the necessary fillip to enhance this cooperation.

This article can be read here.

Nikkei Asia | The Quad should have its own biomanufacturing hub in India

Biomanufacturing, which uses microorganisms and cell cultures to produce molecules and materials on a large scale, is rapidly rising in importance for Indo-Pacific nations. The world's response to COVID-19 depended on the rapid production of new vaccines through biomanufacturing. Countries with preexisting manufacturing capabilities became the gatekeepers of vaccine supply. Scaling up biomanufacturing in India will be fraught with challenges, however, but these can be overcome with external support. The Quad group in particular is ideally placed to collaborate and boost India's efforts.

Read more here

ASPI Strategist | The Quad should commit to a biomanufacturing hub in India

A biological revolution is underway in global manufacturing. Products produced from genetic engineering and biomanufacturing techniques are replacing many chemical, industrial and farm-based products. These include biological therapies, alternative proteins, plant-based oils, bioplastics and super strong threads, and more products such as bioconcrete are in development. The upcoming leaders’ summit in Sydney is an opportunity for the members of the Quadrilateral Security Dialogue to take leadership in manufacturing this critical technology.

Read more here

Deccan Herald | Quad partners can boost India’s biomanufacturing policy

Biotechnology is going to revolutionise the global economy and many countries recognise the need to optimally develop bioresources. According to an OECD report, more than 50 countries have adopted specific policies designed to shape their bio-economies.

In the recent past, the United States and China have also published plans for spurring their bio-economies. India’s Department of Biotechnology has released the 2021-2025 National Biotechnology Development Strategy, which envisions India as a global biomanufacturing hub by 2025.

Can India Take Cues From Kenya's GMO Ban Lift to Meet Climate Change Challenge?

In early October 2022, Kenya lifted a decade-long ban on importing Genetically Modified Organisms or GMOs as a source of food and feed. This follows Kenya's approval to GM cotton in response to the ongoing drought conditions.

Parts of Africa are experiencing unprecendented drought and nearly four million people in Kenya are facing hunger issues. Kenya’s move to adopt GMOs to improve food security comes on the recommendation of a task force which was set up to examine the safety and viability of using GMOs.  

While this move may mitigate some of Kenya’s food concerns, the shift to GMOs in the middle of an ongoing disaster will take time and effort. With this backdrop, it is time for India to also revisit its de facto ban on GMOs and invest in this technology now.

Wastewater surveillance programmes for India: A call for action

New York Governor Kathy Hochul declared a disaster emergency on September 9 2022, to ramp up efforts to vaccinate residents against polio after the virus was detected in wastewater samples in four counties. While wastewater surveillance is an effective tool for monitoring community health, there has been no concerted governmental effort in India to include it in the broader public health strategy.Such a programme could better predict the emergence of diseases, help prepare mitigation measures and improve public health outcomes

Execute Open-Access Mandate for Academia

The United States (US) announced recently that all taxpayer-supported research must be immediately made available to the public at no cost. This will become the norm by the end of 2025. This policy is likely to have worldwide ramifications including India. In the short term, India needs to support its researchers through increased funding and find ways to make Indian publishers globally competitive.

In India, the Dangers of a Single Farming Strategy

Prime Minister (PM) Narendra Modi recently lauded the benefits of natural farming while addressing a natural farming conclave in Surat and indicated that the central government will help expand clusters of natural farms and extend incentives for adoption of the technique. While this is a noble sentiment and there are benefits, India should ensure that the push doesn’t end up becoming an investment in a single farming strategy. Sri Lanka has recently demonstrated how investing in a single solution can result in disastrous results.

How should India's Vaccine Mandate Policy look like?

The recent wave of Covid-19 infections across the United States has been a setback for employers, schools, and universities who were readying to open their offices and campuses. From a "no mask needed for the fully vaccinated" policy 50 days back to vaccines being made compulsory by both state administrations and private companies alike, the Covid-19 vaccine has become imperative for the recovery process from the pandemic.Given the population size of India and the current pace of vaccinations in the country, the threat of future waves of Covid-19 infections still looms large. Recently, employer institutions (both government as well as private) along with public service provider businesses in the country have mandated the Covid-19 vaccine for their employees and customers, respectively.But if there is a vaccine mandate issued in India, what would be the ideal strategy for implementing it?